(Q44924000)

7 December 2017

title

Treat the patients' main dyspepsia complaint, not the ROME criteria (English)

1 reference

7 December 2017

Naoki Chiba

1

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

The American Journal of Gastroenterology

7 December 2017

published in

1 reference

7 December 2017

volume

99

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

1059-1062

1 reference

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Current indications for acid suppressants in dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Symptoms in gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

A Canadian physician survey of dyspepsia management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

Etiology of dyspepsia: implications for empirical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30488.X

10.1111/J.1572-0241.2004.30488.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference